Form 4: Columbia Financial Executive Acquires Shares and Holds Stock Options
SEC Form 4
Oliver Edward Lewis Jr., EVP & Head of Commercial Banking at Columbia Financial, Inc., reports acquisition of common stock and holdings of stock options.
Summary
- Oliver Edward Lewis Jr., a top executive at Columbia Financial, Inc. (CLBK), filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On May 31, 2024, Lewis acquired common stock through a stock-based deferral plan at a price of $14.5 per share.
- He indirectly owns 4,238.2521 shares through the Stock-Based Deferral Plan, 5,353 shares through the ESOP, 2,457 shares through the SERP, 441 shares through the SIM, 715 shares through a stock award, 14,591 shares through Stock Award III, and 12,672 shares through Stock Award IV.
- Lewis also holds stock options to purchase 17,647 shares at $17, 57,026 shares at $17.86, 11,579 shares at $15.94 and 8,518 shares at $16.49.
- These stock options vest at various dates between July 23, 2020, and March 6, 2025, and expire between March 22, 2031, and March 6, 2034.
- The stock awards vest in installments, some based on time and others on performance criteria.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing transactions. The acquisition of shares by an executive is mildly positive, but not significantly so.
Positives
- The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
- The vesting schedules of the stock options and awards incentivize long-term performance and alignment with shareholder interests.
Risks
- The value of the stock options is dependent on the future performance of Columbia Financial, Inc.'s stock price.
- Performance-based vesting criteria for some stock awards introduce uncertainty regarding whether those awards will fully vest.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge executive sentiment and potential future stock performance.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a positive signal.
- Employees may be motivated by the executive's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Stock Options (right to buy) $ 17 vest in five approximately equal annual installments commencing on this date. |
| 03/22/2022 | Stock Options (right to buy) $ 17.86 are fully vested and exercisable as of this date. |
| 05/01/2024 | Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on this date; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award. |
| 05/01/2024 | Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on this date. |
| 05/31/2024 | Date of transaction where common stock was acquired. |
| 03/06/2025 | Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on this date; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award. |
| 03/06/2025 | Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on this date. |
| 07/23/2029 | Expiration date for Stock Options (right to buy) $ 17. |
| 03/22/2031 | Expiration date for Stock Options (right to buy) $ 17.86. |
| 05/01/2033 | Expiration date for Stock Options (right to buy) $ 15.94. |
| 03/06/2034 | Expiration date for Stock Options (right to buy) $ 16.49. |
| 06/04/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.